0000899140-23-000886.txt : 20230814 0000899140-23-000886.hdr.sgml : 20230814 20230814163029 ACCESSION NUMBER: 0000899140-23-000886 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarissa Capital Management LP CENTRAL INDEX KEY: 0001577524 IRS NUMBER: 900924432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15935 FILM NUMBER: 231170916 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001577524 XXXXXXXX 06-30-2023 06-30-2023 false Sarissa Capital Management LP
660 STEAMBOAT ROAD GREENWICH CT 06830
13F HOLDINGS REPORT 028-15935 N
Alexander J. Denner, Ph.D. Chief Investment Officer 203-302-2330 /s/ Alexander J. Denner Greenwich CT 08-14-2023 0 11 1004526158
INFORMATION TABLE 2 informationtable.xml ALKERMES PLC SHS G01767105 439452000 14040000 SH SOLE 14040000 0 0 AMARIN CORP PLC SPONS ADR NEW 023111206 5842900 4910000 SH SOLE 4910000 0 0 BIOCRYST PHARMACEUTICALS INC COM 09058V103 5456000 775000 SH SOLE 775000 0 0 BIOGEN INC COM 09062X103 183158550 643000 SH SOLE 643000 0 0 GILEAD SCIENCES INC COM 375558103 70935228 920400 SH SOLE 920400 0 0 INNOVIVA INC COM 45781M101 92636210 7277000 SH SOLE 7277000 0 0 IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 174389600 16390000 SH SOLE 16390000 0 0 MERSANA THERAPEUTICS INC COM 59045L106 8662241 2632900 SH SOLE 2632900 0 0 NEUROCRINE BIOSCIENCES INC COM 64125C109 21811590 231300 SH SOLE 231300 0 0 REGULUS THERAPEUTICS INC COM 75915K309 272219 185183 SH SOLE 185183 0 0 VOR BIOPHARMA INC COM 929033108 1909620 618000 SH SOLE 618000 0 0